Shares of Alliance Pharma plc (LON:APH – Get Free Report) reached a new 52-week high on Wednesday . The company traded as high as GBX 61.50 ($0.75) and last traded at GBX 61.20 ($0.75), with a volume of 4399260 shares changing hands. The stock had previously closed at GBX 61.10 ($0.75).
Alliance Pharma Price Performance
The firm has a 50-day simple moving average of GBX 47.38 and a 200-day simple moving average of GBX 42.56. The firm has a market capitalization of £330.26 million, a PE ratio of -1,018.25, a PEG ratio of 1.04 and a beta of 0.67. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42.
Alliance Pharma Company Profile
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Read More
- Five stocks we like better than Alliance Pharma
- What is Put Option Volume?
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Canada Bond Market Holiday: How to Invest and Trade
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
